Study for people newly diagnosed with inflammatory bowel disease
Part of Digestive system, Immune system & allergy clinical trials.
This trial studies treatment approaches for inflammatory bowel disease (IBD) in people who are newly diagnosed. It may help researchers find better care by learning how well the study treatment works early in the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been newly diagnosed with inflammatory bowel disease (IBD)
- You should be able to give informed consent (understand and agree to join)
- You must be able to follow the study treatment plan as instructed
- You should not have had IBD before (including treatment changes) in the last 10 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune system changes in people around the time inflammatory bowel disease (IBD) is first diagnosed, and compares different groups (new, very recent, or not found on scope). It may help researchers understand what the immune system looks like early in IBD and later in people who don’t show it on colonoscopy.
This trial looks at how to diagnose Inflammatory Bowel Disease (IBD) in people who have just been diagnosed. It may help find better ways to detect and manage the condition.
This trial looks at early signs of inflammatory bowel disease (IBD) in adults who have had stomach or bowel symptoms for at least 3 weeks. It aims to understand how the disease progresses.
This study tests whether taking probiotics can help prevent or treat inflammatory bowel disease (IBD) in people recently diagnosed. It aims to see if friendly bacteria can calm gut inflammation and improve symptoms.
This trial collects information from children who are newly diagnosed with inflammatory bowel disease (IBD) and follows them to understand safety in real life. It may help doctors improve early diagnosis and treatment planning for kids with IBD.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
Hear when a new IBD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.